Sotabase

Career

· Associate Director of Grants and Finance, Columbia University2023–
· Grants Administrator, Columbia University Irving Medical Center2015–2023

Publications (39)

Use of PER977 to reverse the anticoagulant effect of edoxaban.
New England Journal of Medicine · 2014
430
cited
Oral delivery of proteins by biodegradable nanoparticles.
Advanced Drug Delivery Reviews · 2013
163
cited
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
Thrombosis and Haemostasis · 2016
135
cited
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin.
Thrombosis Research · 2016
76
cited
Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking
International Journal of Nanomedicine · 2012
57
cited
Ciraparantag, an Anticoagulant Reversal Drug: Mechanism of Action, Pharmacokinetics and Reversal of Anticoagulants.
Blood · 2020
49
cited
Abstract 11395: Small Molecule Antidote for Anticoagulants
2012
44
cited
TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness.
Cancer Research · 2013
40
cited
Nonclinical Safety Assessment of PER977
International journal of toxicology · 2015
39
cited
Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
European Heart Journal · 2021
36
cited
Reversal Agents in Development for the New Oral Anticoagulants
Postgraduate medicine · 2014
36
cited
Direct and cell signaling-based, geometry-induced neuronal differentiation of neural stem cells.
Integrative Biology · 2011
30
cited
Abstract 18809: PER977: A Synthetic Small Molecule Which Reverses Over-Dosage and Bleeding by the New Oral Anticoagulants
Circulation · 2013
21
cited
Abstract 19361: Reversal of Anticoagulant-induced Bleeding in External and Internal Bleeding Models by PER977, a Small Molecule Anticoagulant Antidote
2014
21
cited
PER977 REVERSES LOW MOLECULAR WEIGHT HEPARIN IN ADDITION TO IIA AND XA NEW ORAL ANTICOAGULANTS
2015
18
cited
A synthetic small molecule antidote for anticoagulants
2013
17
cited
Three-dimensional microfiber devices that mimic physiological environments to probe cell mechanics and signaling.
Lab on a Chip · 2012
13
cited
A Novel Whole Blood Point-of-Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins
Seminars in Thrombosis and Hemostasis · 2018
12
cited
The new oral anticoagulants: clinical use and reversal agent development
2015
9
cited
Playing to win
Nature Biotechnology · 2009
8
cited
Sotabase
Eola Bakhru | Researcher Profile | Sotabase | Sotabase